anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Summit Therapeutics · consulting-deck

2026 Investor Deck

15 pages · 4 arc beats · 2 loops

Consulting-Deck Download JSON
Unlock

2026 Investor Deck

Summit Therapeutics
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 4 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 12 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides · 2 hits Product 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides · 2 hits Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Financials 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides

Slide inventory

15
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
Includes specific disclaimer about ivonescimab regulatory status and copyright information.other
Open slide detail
03
The slide highlights a major regulatory milestone for the company's lead asset.summarize
Open slide detailLoop · Cost Of Inaction
04
Includes both Summit and Akeso trials.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
05
The slide uses a scientific illustration to explain the molecular mechanism of a bispecific antibody.present_solution
Open slide detailLoop · Cost Of Inaction
06
The table uses a visual bar representation for clinical trial phases (1/1b, 2, 3).summarize
Open slide detailBeat · ProductLoop · Cost Of Inaction
07
Includes a table of clinical trials, callout boxes for collaborations and research support, and a forward-looking statement about Q1 2026.present_solution
Open slide detailLoop · Cost Of Inaction
08
The slide uses a structured grid to compare four distinct clinical trial programs.illustrate_case
Open slide detailLoop · Cost Of Inaction
09
The slide presents clinical trial data for Ivonescimab in NSCLC, showing consistent HR improvements across different patient populations.quantify_impact
Open slide detailLoop · Cost Of Inaction
10
The slide uses a dual-column timeline layout to track progress of various HARMONI clinical trials.summarize
Open slide detailLoop · Cost Of Inaction
11
The slide uses a checkmark visual to indicate positive outcomes for each clinical question posed.summarize
Open slide detailLoop · Cost Of Inaction
12
The slide uses a timeline framework to communicate upcoming clinical trial readouts and regulatory events.plan_implementation
Open slide detailLoop · Cost Of Inaction
13
The slide highlights a strong liquidity position with significant cash and zero debt.summarize
Open slide detailBeat · FinancialsLoop · Cost Of Inaction
14
The slide uses a visual flow to aggregate market sizes and point toward future growth areas.size_opportunity
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
15
other
Open slide detailLoop · Cost Of Inaction